← SynDRA
Ginsenoside K
SynDRA canonical compound SYN1486431 — structure-anchored drug synonym record
Clinical phase
Phase 1
Primary target(s)
CASP3 | NR3C1 | PTGS2
Mechanism of action
NFkB pathway inhibitor | nitric oxide synthase inhibitor
Cross-references
PubChem CID:
9852086
ChEMBL:
CHEMBL3355096
ChEBI:
77146
KEGG:
C22127
Synonyms
RefChem:639972
ginsenoside-C-K
ginsenoside CK
ginsenoside compound K
ginsenoside M1
MFCD07772261
3-O-Deglucosylginsenoside F2
Protopanaxadiol 20-O-glucoside
CHEBI:77146
G8D4792Q7K
GM1 saponin
IH901 cpd
ginsenosideCK
CompoundK
Compound-K
Compound CK
Ginsenoside compound K; Ginsenoside K
IH901
Ginsenoside metabolite M1
Ginsenoside K (Standard)
(20S)-ginsenoside C-K
NT3 VAN SC6
Ginsenoside C-K (Standard)
UNII-G8D4792Q7K
orb1303718
orb3139325
SCHEMBL18179307
GLXC-03739
HY-N0904
BDBM50023446
IH 901
s9105
AKOS037514664
CCG-270260
CS-3840
EBC-615548
MG33283
AC-33947
AS-82692
Look up Ginsenoside K in the interactive SynDRA portal →